Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner

We have recently established a cancer-reactive human monoclonal antibody, GAH, with a positive ratio of over 90% against stomach cancer. GAH was formulated as polyethyleneglycol (PEG)-modified immunoliposomal doxorubicin (DXR) (ILD) and its efficacy was examined against gastrointestinal human cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosokawa, S, Tagawa, T, Niki, H, Hirakawa, Y, Nohga, K, Nagaike, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394358/
https://www.ncbi.nlm.nih.gov/pubmed/14562030
http://dx.doi.org/10.1038/sj.bjc.6601341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394358/
https://www.ncbi.nlm.nih.gov/pubmed/14562030
http://dx.doi.org/10.1038/sj.bjc.6601341

Ejemplares similares